International Clinical Psychopharmacology

Papers
(The H4-Index of International Clinical Psychopharmacology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Beyond antipsychotics: the role of medication and nonmedication factors in female sexual dysfunctions in schizophrenia40
Immunomodulatory options for neurodevelopmental spectrum conditions: are we there yet?32
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?24
Catatonia as a debut of systemic lupus erythematosus: a case report on a diagnostic challenge20
Venlafaxine for tramadol dependence and medical cannabis therapy for generalized anxiety disorder19
Sleep disturbance in schizophrenia spectrum disorders: more than just a symptom?18
Age matters when improving symptoms of anxiety, depression, and sleepiness in patients with obstructive sleep apnea treated with continuous positive airway pressure16
Impact of selected second and third generation antipsychotics on cognitive dysfunction in schizophrenia-spectrum disorders. Systematic review and network meta-analysis16
Clinical specificity profile for novel rapid acting antidepressant drugs15
Open issues in bipolar and antipsychotic treatments15
Managing depression in the elderly: real-world clinical considerations and perspectives15
Acceptability-adjusted speed in psychotic agitation: interpreting pro re nata antipsychotic data in real-world care (commentary on Hatta et al.)14
Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case14
Preliminary evidence that blood extracellular nicotinamide phosphoribosyltransferase increases with antidepressant response to chronotherapeutics and to monoaminergic drugs14
0.097323894500732